Global Pancreatic Cancer Diagnostics Market is expected to grow with the CAGR of 7.5% in the forecast period of 2023 to 2030. The years considered for study are as mentioned below:
Access Full Report @ https://www.databridgemarketresearch.com/pt/reports/global-pancreatic-cancer-diagnostics-market
Global pancreatic cancer diagnostics market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in global pancreatic cancer diagnostics market are introducing strong range of product providers along with launching new services and adopting strategic initiative such as acquisition, agreement, business expansion, awards and recognition into the market. This helped the companies to maximize the sales with enhanced service portfolio.
- In December 2022, FUJIFILM Holdings America Corporation announced the company has purchase agreement asset with Inspirata, Inc. to acquire digital pathology business to expand robust enterprise imaging offering. This results in enabling the integration of pathology images and data into a healthcare organization’s electronic health record system to streamline care delivery for oncology patients.
- In August 2020, Siemens Healthcare GmbH announced that it has entered in to an agreement with Varian Medical Systems, Inc. With this acquisition, Siemens Healthcare has helped in developing advanced solutions to treat against cancer and strengthen their position in healthcare industry.
CANON MEDICAL SYSTEMS CORPORATION is the dominating player in the market. The other key players existing in the market includes Siemens Healthcare GmbH, Koninklijke Philips N.V., FUJIFILM Corporation, Grail, Laboratory Corporation of America Holdings, DiaSource, Abbott, Agilent Technologies, Inc., Lee Biosolutions, Inc, MP BIOMEDICALS, Setia Scientific Solution, Boditech Med Inc., AccuBioTech Co., Ltd., Thermo Fisher Scientific, Creative Biolabs, Myriad Genetics, Inc., BD, QIAGEN, Meridian Life Science, Inc., and CTK Biotech, Inc., among others.
CANON MEDICAL SYSTEMS CORPORATION
CANON MEDICAL SYSTEMS CORPORATION is headquartered in Tochigi Prefecture, Japan and was founded in year 1930. The company is focused on delivering innovative imaging solutions and services to improve the quality of life for people. The business segment include printing, imaging, medical, and industrial and others, whereas the market focused segment is medical. The product categories include angiography, computed tomography, magnetic resonance, ultrasound, x-ray, nuclear medicine, healthcare IT, and RE amplifier components. The market focused categories include computed tomography, magnetic resonance and ultrasound.
- In July 2022, Canon Medical Systems USA Inc. announced the completion of the acquisition of NXC Imaging, a medical imaging equipment distributor and service provider located in Minnesota, U.S. This results in expanding the service outreach in the global market.
The company has a presence in the North America, Europe, Asia-Pacific, and South America. The company has various subsidiaries include Canon Precision Inc., Canon Tokki Corporation, Fukushima Canon Inc., Canon Medical Systems Corporation, Canon Electron Tubes & Devices Co., Ltd., Canon Components, Inc., Canon Semiconductor Equipment Inc., Canon Chemicals Inc, among others.
KONINKLIJKE PHILIPS N.V.
Koninklijke Philips N.V. is headquartered in Amsterdam, Netherland and was founded in year 1891. The company focused on improving people’s health and well-being through meaningful innovation. The business segment include diagnosis & treatment businesses, connected care businesses, personal health businesses, and others, whereas the market focused segment is diagnosis & treatment businesses. The product categories include advance molecular nuclear imaging, computed tomography, customer services solutions, diagnostic ECG, diagnostic informatics, emergency care &resuscitation, fluoroscopy, hospital respiratory care, image-guided therapy, MRI systems & solutions, pathology, patient monitoring solutions, radiation oncology, radiography/x-ray & fluoroscopy solutions, refurbished system, service part, sleep and respiratory care, supplies, ultrasound, value products, and ventilation. The market focused category is patients care monitoring.
- In October 2021, Koninklijke Philips N.V. announced that Philips Capsule Medical Device Information Platform (MDIP) had exceeded the milestone of integrating with more than 1,000 unique medical device models. Philips Capsule MDIP, which will be integrated into the Philips HealthSuite Platform, is now installed in more than 3,000 healthcare facilities globally. This results in improving collaboration between care teams, streamline clinical workflows, and increase productivity that helps to increase the company's revenue in the market.
The company has a presence in the North America, South America, Europe, Asia-Pacific, and Middle East and Africa. The company has subsidiaries as Philips Argentina Sociedad Anónima (Argentina), Philips Domestic Appliances Australia Pty Ltd (Australia), Philips Vietnam Limited (Vietnam), and Philips Uruguay S.A. (Uruguay), among others.
SIEMENS HEALTHCARE GMBH
Siemens Healthcare GmbH is headquartered in Erlangen, Germany and was founded in year 1847. The company is engaged in providing various healthcare solutions and services of imaging, diagnostics and advanced therapies.The business segment include imaging, diagnostics, varian and advanced therapies, whereas the market focused segment is diagnostics. The product categories include medical imaging, cancer care, laboratory diagnostics, point-of-care testing, clinical fields and digital health solutions.
The market focused categories include laboratory diagnostics.
- In August 2020, Siemens Healthcare GmbH entered into an agreement with Varian Medical Systems, Inc. With this acquisition, Siemens Healthcare has helped in developing advanced solutions to treat cancer and strengthen its position in the healthcare industry.
The company has a presence in the North America, South America, Europe, Asia-Pacific, and Middle East and Africa. The company has various subsidiaries such as Siemens Japan K.K. (Japan), Siemens Healthcare Diagnostics GmbH (Germany), Siemens Healthcare SA (Switzerland), P.E.T.NET Houston, LLC (U.S.), among others.
